Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1213.117 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1213.117/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.117 |
Version | 20240924 |
Status | active |
Date | 2024-09-24T01:00:40-04:00 |
Name | ClopidogrelIngredientsAndRiskOfGIBleeding |
Title | Clopidogrel Ingredients and Risk of GI Bleeding |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: This value sets contains CLOPIDOGREL ingredients to provide the estimate risk of GI bleeding when using the SDM tool),(Data Element Scope: The intent of this data element is to identify patients who are on clopidogrel),(Inclusion Criteria: Includes RxNorm codes (Rx CUI) for clopidogrel medications),(Exclusion Criteria: Excludes concepts that describe non-clopidogrel ingredients.) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113762.1.4.1213.117", "meta": { "versionId": "5", "lastUpdated": "2024-09-24T01:00:40.000-04:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "Meaningful Drug Interaction Alerts Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2024-09-24" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2024-09-24" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.117", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113762.1.4.1213.117" } ], "version": "20240924", "name": "ClopidogrelIngredientsAndRiskOfGIBleeding", "title": "Clopidogrel Ingredients and Risk of GI Bleeding", "status": "active", "date": "2024-09-24T01:00:40-04:00", "publisher": "Meaningful Drug Interaction Alerts Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: This value sets contains CLOPIDOGREL ingredients to provide the estimate risk of GI bleeding when using the SDM tool),(Data Element Scope: The intent of this data element is to identify patients who are on clopidogrel),(Inclusion Criteria: Includes RxNorm codes (Rx CUI) for clopidogrel medications),(Exclusion Criteria: Excludes concepts that describe non-clopidogrel ingredients.)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "236991", "display": "clopidogrel bisulfate" }, { "code": "32968", "display": "clopidogrel" } ] } ] }, "expansion": { "identifier": "urn:uuid:b34eeedb-80f8-4aba-b250-a8517608f393", "timestamp": "2025-05-23T19:20:34-04:00", "total": 2, "contains": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "236991", "display": "clopidogrel bisulfate" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "32968", "display": "clopidogrel" } ] } }